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Despite the prominence of carbohydrate-specific antibodies in human sera, data on their
emergence and antigen specificities are limited. Whereas maternal IgG are transferred
prenatally to the fetal circulation, IgM present in cord blood originate from fetal B
lymphocytes. Considering the limited exposure of the fetus to foreign antigens, we
assessed the repertoire of carbohydrate-specific antibodies in human cord blood
and matched maternal blood samples using glycan arrays. Carbohydrate-specific IgM
was absent in cord blood, whereas low cord blood IgG reactivity to glycans was
detectable. Comparing IgG reactivities of matched pairs, we observed a general lack of
correlation in the antigen specificity of IgG from cord blood and maternal blood due to a
selective exclusion of most carbohydrate-specific IgG from maternofetal transfer. Given
the importance of intestinal bacteria in inducing carbohydrate-specific antibodies, we
analyzed global antibody specificities toward commensal bacteria. Similar IgG reactivities
to specific Bacteroides species were detected in matched cord and maternal blood
samples, thus pointing to an efficient maternal transfer of anti-microbial IgG. Due to
the observed selectivity in maternofetal IgG transfer, the lack of fetal antibodies to
carbohydrate epitopes is only partially compensated by maternal IgG, thus resulting in a
weak response to carbohydrate antigens in neonates.
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INTRODUCTION
Carbohydrate-specific antibodies represent a large fraction of circulating IgM and IgG. These
antibodies mainly recognize alloantigens, such as ABO and Lewis blood groups (1, 2), and
xenoantigens, including α-rhamnose, Forssman, and Galili antigens (3–5). Whereas allo-antigen
specific carbohydrate-specific antibodies are relevant in transfusion medicine, carbohydrate-
specific antibodies generally protect against infections by targeting carbohydrate antigens expressed
by pathogens, such as bacterial capsular polysaccharides (6) and surface glycoproteins of
parasites (7).
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Carbohydrate-specific antibodies develop early in life (8, 9),
mainly following the colonization of the gastrointestinal tract
with microbes, which stimulate the infant’s immune system
(10). ABO-specific antibodies typically occur postnatally as the
result of the exposure to bacterial glycans mimicking ABO
antigens (11). The transfer of maternal IgG through the placenta
provides an additional level of protection to the newborn. IgG
is the only immunoglobulin class that can pass the placenta by
binding to the neonatal Fc receptors (FcRn) expressed at the
syncytiotrophoblast (12). At time of birth, IgG levels in cord
blood reach adult levels and often even exceed maternal levels
(13). Most cord blood IgG are considered to be of maternal origin
(14). Maternally-transferred IgG have been mainly investigated
in the context of vaccine protection toward Bordetella pertussis
(15), Staphylococcus (16), Haemophilus influenzae (17), and
Streptococcus pneumoniae (18). Differences in the efficiency of
placental antibody transfer may relate to antigen properties
and the IgG subclass involved (19). Antibodies to bacterial
polysaccharides are mainly of IgG2 subclass, which is less
efficiently transferred to the fetal circulation through FcRn (20).
On the contrary, the cord blood levels of IgG to xenoantigens,
such as α-rhamnose and the Forssman antigen, and to bacterial
lipopolysaccharides from Escherichia coli O16, O6, and O111
have been shown to be at least as high as in matched maternal
samples (21, 22).
In contrast to IgG, IgM levels in cord blood are low (23,
24), as they are solely derived from the developing immune
system of the fetus (25). These IgM are classified as natural
antibodies without antigen-driven maturation (26), although
pre-natal immune stimulation by antigens transferred from
the maternal circulation (27, 28) or by bacteria occurring in
utero have to be considered. The presence of bacteria in utero,
however, is controversial (29) as the fetal environment is largely
considered to be sterile (30, 31). Isolated studies reported the
presence of bacteria in meconium (32), amniotic fluid (33),
cord blood (34), and placental tissue (33, 35). Accordingly, the
occurrence of cord blood IgM targeting bacterial glycoconjugates
and carbohydrates in general is unclear. IgM to some glycans
have been described in cord blood (26), whereas other studies
reported that carbohydrate-specific antibodies are absent during
the first weeks of life (36).
To characterize the repertoires of maternally transferred
and endogenous carbohydrate-specific antibodies at birth,
we compared the reactivity of IgG and IgM toward
carbohydrate antigens in matched maternal and cord blood
samples. The analysis of antibody binding to an array of
human oligosaccharides pointed to striking differences in
the reactivity of maternal and neonatal antibodies toward
carbohydrate antigens.
RESULTS
Carbohydrate-Specific IgG and IgM in
Cord Blood and Maternal Blood
The concentrations of IgG and IgM in cord blood increased
with gestational age, where the IgG concentration in cord blood
from full-term neonates with a gestational age of at least 37
weeks reached between 10 and 20 mg/ml, which is within
the range of IgG concentrations in maternal blood (Figure 1A,
Supplementary Table 1). Direct comparison of matched cord
and maternal blood samples showed no correlation in respect
to IgG concentration. Notably, high IgG concentrations in
maternal blood were mainly associated with lower concentration
in matched cord blood samples (Figure 1B).
IgM concentration in cord blood also increased with
gestational age (Figure 1C), although at term IgM concentration
remained significantly lower than the concentration of
about 1 mg/ml measured in maternal blood (Figure 1D,
Supplementary Table 1). In contrast to IgG, the levels of IgM
in neonatal cord blood were consistently lower than the serum
IgM concentration in the matched maternal blood samples
(Figure 1D).
To compare the antigenic repertoire of carbohydrate-specific
antibodies in matched cord blood and maternal blood samples,
we focused on neonates delivered at full term to maintain
consistency in IgM and IgG levels. The sample population
investigated comprised 26 pairs of matched cord blood and
maternal blood samples. IgG concentrations in this group of
samples averaged 14.6 ± 4.7 mg/ml for cord blood samples
and 13.7 ± 5.0 mg/ml for maternal blood samples. IgM
concentrations were 0.6 ± 0.1 mg/ml in cord blood samples and
1.0± 0.3 mg/ml in maternal blood samples.
Carbohydrate antigen specificity of IgG and IgM in matched
cord blood and maternal blood samples was investigated using
an array displaying 220 different human oligosaccharides (37).
The oligosaccharide structures tested represented common
carbohydrate epitopes found on human cells and occurring on
bacterial glycoconjugates expressed by intestinal commensals
(11, 38). Most oligosaccharides displayed on the array were
characterized by their mass composition consisting of hexose
(H), N-acetyl-hexosamine (N), fucose (F) and the sialic acid N-
acetylneuraminic acid (S). Antibody binding to oligosaccharides
was calculated as the mean fluorescence intensity of four
replicates for each oligosaccharide.
The comparative analysis of 26 maternal blood samples
revealed a large inter-individual variability in the range and
intensity of oligosaccharide binding by IgG across samples
(Figure 2A).Whereas isolated samples showed a strong reactivity
toward oligosaccharides (samples MB13, MB21 on Figure 2A),
others showed only a minor reactivity to few oligosaccharides
(samples MB4, MB9 on Figure 2A). The difference in the
average binding intensity to oligosaccharides exceeded a 100-fold
between the least and the most reactive maternal blood samples
(Figure 2B). The reactivity of IgG to oligosaccharides in cord
blood samples was on average 10-fold lower than in the maternal
blood samples, whereas a large inter-individual difference was
also evident between the samples tested (Figure 2A).
Given that the placental transfer of antibodies is restricted
to the IgG class, the amount and reactivity of IgM detected
in cord blood samples reflect the endogenous production by
the fetal immune system (25). In contrast to IgG, cord blood
IgM largely did not react with the oligosaccharide antigens
on the array (Figure 2A). Maternal blood IgM showed a
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FIGURE 1 | IgM and IgG concentrations in cord blood depend on the gestational age. (A) IgG concentration of cord blood samples dependent on the gestational age
(n = 42). (B) IgG concentrations of cord blood (CB) and matched maternal blood (MB) (n = 31). Red dots indicate samples from pre-term neonates (n = 5). (C) IgM
concentrations of cord blood dependent on the gestational age (n = 42). (D) IgM concentrations of cord blood (CB) and maternal blood (MB) (n = 31). Green dots
indicate samples from pre-term neonates (n = 5). Results with p-value < 0.05 are marked with asterisks.
strong reactivity to oligosaccharides in a similar way to the
signals recorded for IgG (Figure 2A). Individual recognition
patterns and signal intensities for IgG and IgM of the
same serum strongly overlapped (Supplementary Figure 1).
Correlation analysis confirmed that repertoires of carbohydrate-
specific IgG and IgM correlate significantly for each maternal
blood serum (Supplementary Table 1), clearly showing the lack
of cord blood IgM reactivity toward oligosaccharides.
The partition of oligosaccharides into fucosylated, sialylated
and undecorated structures did not reveal any major differences
in reactivity between cord blood and maternal blood IgG. When
focusing on non-fucosylated and non-sialylated oligosaccharides,
some cord blood samples contained only marginal levels of
IgG recognizing such undecorated oligosaccharides, whereas
the corresponding maternal blood samples displayed strong
reactivity toward this group of oligosaccharides (Figure 3A).
Similar differences were visible for the abundance of IgG reactive
toward individual groups of fucosylated oligosaccharides, where
IgG reactivity was absent or extremely low in cord blood
samples despite a high IgG reactivity in the matched maternal
samples (Figure 3B). The same trend was observed for di-
sialylated oligosaccharides, regardless of the fucosylation status
(Figure 3C). Focusing on single glycan structures, we selected the
glycans with the highest average IgG reactivity in the cord blood
group. Two glycans displayed a mean RFU higher than 1,000 for
the cord blood group and additional strong IgG reactivity for 24
out of 26 maternal blood samples (Figures 3D,E). Interestingly,
strong maternal IgG reactivity did not always lead to high
levels of IgG binding in matched cord blood, as illustrated by a
subgroup of samples (Figures 3D,E). For six maternal samples
with a comparable and strong IgG reactivity to structure S1, only
one matched cord blood sample displayed the same strength in
IgG binding to the same glycan. Compared with the matched
maternal samples, the other five cord blood samples resulted
in weaker IgG binding, still leading to strong recognition of
structure S1 in one case and weak responses for three samples.
Interestingly, despite the high levels of IgG reactivity observed
in the matched maternal blood, one cord blood sample did
not show any IgG binding to the same glycan (Figure 3D). A
similar pattern was observed for the second glycan structure
S2 (Figure 3E). The discrepancy in the IgG reactivity between
cord blood and matching maternal blood samples pointed to a
selective transfer of maternal carbohydrate-specific IgG to the
fetal circulation.
The direct comparison of IgG reactivity profiles toward
oligosaccharide antigens in the 26 matched pairs of cord blood
and maternal blood samples confirmed the general lack of
correlation in antigen specificity. Only six pairs displayed visible
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FIGURE 2 | Carbohydrate-specific IgG is lower in cord blood than in matched maternal blood, whereas carbohydrate-specific IgM is absent in cord blood. (A)
Heatmaps of the serum IgG and IgM reactivity to 220 different glycans measured by glycan array analysis, displayed for 26 matched pairs of cord blood (CB1-26) and
maternal blood (MB1-26). (B) Quantification of cord blood (CB) and maternal blood (MB) IgG and IgM reactivity to glycans measured by arrays. Results with p-value
< 0.05 are marked with asterisks.
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FIGURE 3 | Low maternal transfer of carbohydrate-specific IgG. (A) Mean IgG reactivities to subgroups of glycans on the array shown as log (RFU) for cord blood
(CB) and maternal blood (MB) samples. (B) Analysis of subgroups of fucosylated glycans (mono-fucosylated, F1; di- to tetra-fucosylated, F2–F4) (C) Analysis of
(Continued)
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FIGURE 3 | subgroups of sialylated glycans (mono-sialylated, S1; di-sialylated, S2). (D,E) IgG reactivities of CB and MB samples to glycan structures S1 and S2. A
subgroup of samples with comparable maternal IgG reactivity is marked in red. The composition of glycans is indicated by the number of different monosaccharides
(hexose, H; HexNAc, N; fucose, F; sialic acid, S). All panels comprise 26 matching cord blood samples and maternal blood samples. Connecting lines between CB
and MB dots highlight matching samples with low IgG reactivity in CB. Results with p-value < 0.05 are marked with asterisks.
FIGURE 4 | Repertoires of carbohydrate-specific IgG only partially overlap in matched maternal blood and cord blood. Heatmaps representing the profile of
carbohydrate-specific IgG in 26 matched pairs of cord blood (C) and maternal blood (M). Pairs with visible overlaps in the IgG repertoires are indicated by an asterisk.
overlaps in IgG binding patterns (Figure 4). Correlation analysis
of normalized IgG reactivities demonstrated that carbohydrate-
specific IgG profiles of maternal and cord blood strongly
correlated (r > 0.67) only for two of 26 pairs (CB2/MB2,
CB22/MB22), whereas three pairs showed a moderate correlation
(r= 0.36–0.67) and 21 pairs did not or only weakly correlate (39)
(Table 1).
Limited transfer of carbohydrate-specific antibodies may be
explained by differences in IgG subclasses specifically recognizing
carbohydrate antigens. IgG2 is the major subclass of IgG induced
to carbohydrate antigens (40, 41), even though other subclasses
are involved in anti-carbohydrate responses (42). As the placental
transport of IgG2 is less efficient compared with the transport
of other IgG subclasses (43), limited transfer of carbohydrate-
specific antibodies may be linked to limited transfer of the
IgG2 subclass. Testing IgG2 concentrations in cord blood and
maternal blood, we determined the IgG2 transfer rate for the 26
pairs by calculating the proportion of IgG2 in cord blood to IgG2
in matched maternal blood (44). The mean IgG2 transfer rate of
95.5 ± 51.5% was lower than total IgG transfer rate of 120.5 ±
52.5% (Supplementary Figure 2).
Efficient Maternal Transfer of IgG Directed
to Commensal Bacterial Antigens
Gut bacteria play an important role in the emergence
of carbohydrate-specific antibodies (3, 45). Maternal IgG
significantly contribute to the protection of the neonate
from bacterial infection through placental transfer to the
fetal circulation (15–18). To determine whether the selective
placental transfer of IgG detected for carbohydrate antigens also
affected the recognition of commensal bacteria by cord blood
IgG, we compared the reactivity of matched cord blood and
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maternal blood samples to representative species of commensal
Bacteroides bacteria. The phylum of Bacteroidetes is one of the
major phyla of the human gut microbiota including a variety
of species, where the Bacteroides are known for their high
diversity in surface glycoconjugates (11, 46). All matched cord
blood and maternal samples tested showed similar global IgG
reactivities to B. intestinalis, B. thetaiotaomicron, and B. vulgatus
(Figures 5A–E), where mean IgG reactivities for maternal and
cord blood were on the same level (Figures 5A,C,E). Also
the patterns of reactivity between matched pairs of cord
blood and maternal blood samples overlapped as assessed by
flow cytometry histograms (Figures 5B,D,F). The similarity in
antibody reactivity toward the Bacteroides species clearly showed
that maternal IgG targeting bacterial antigens were efficiently
transferred to the fetal circulation. By contrast, IgM reactivity
to these three Bacteroides species was absent in cord blood
samples, whereas elevated reactivities were measured in maternal
blood samples (Figures 6A,C,E). The comparison of individual
matching cord blood andmaternal blood pairs clearly underlined
the lack of IgM transfer from the maternal circulation to the fetus
(Figures 6B,D,F). The absence of IgM specific to the Bacteroides
species tested in cord blood also indicated that the fetal immune
system was not primed to these commensals prior to delivery,
thus supporting the idea that prenatal exposure to gut microbes
is insignificant and insufficient to stimulate the production of
specific antibodies. To further document the similarity in antigen
recognition between matched neonatal and maternal blood
derived IgG, the reactivity of selected matched samples toward
Bacteroides cell lysates was investigated using Western blotting.
This analysis confirmed the strong inter-individual variability in
antigen recognition between maternal blood samples, as shown
by the different patterns of bands recognized by individual
samples (Figure 7). The analysis also demonstrated the similarity
in antigen recognition betweenmatched cord blood andmaternal
blood samples, thereby underlining the placental transfer of
maternal IgG to commensal bacteria into the fetal circulation.
DISCUSSION
In this study, we showed that maternal carbohydrate-specific
IgG are only partially transferred to the fetus, whereas IgG
directed to bacterial antigens in general are efficiently passed
from the mother to the fetus prior delivery. We also showed
that carbohydrate-specific IgM are lacking at birth, reflecting the
absence of maternal transfer for this class of immunoglobulins
and the lack of prenatal IgM production. In line with previous
studies, IgG concentrations of cord blood correlated with
gestational age and reached maternal levels in full-term neonates
(12, 23, 43). Interestingly, high levels of maternal IgG led to lower
levels of cord blood IgG, suggesting that FcRn receptor-mediated
placental transfer can be saturated (43).
Carbohydrate-specific IgG reactivity in cord blood was
generally low in comparison with maternal blood, which
presented diverse and specific repertoires of carbohydrate-
specific IgG, as reported previously (47). Reactivity to
carbohydrate antigens only correlated for few pairs of matched
cord blood and maternal blood samples. Most cord blood
samples tested showed a low and diffuse glycan reactivity,
indicative of a limited pool of maternal IgG transferred to
the fetal circulation. Limited transfer of carbohydrate-specific
antibodies may be partially explained by decreased affinity of
the FcRn receptor for IgG2 (20), which have been shown to
encompass a large pool of carbohydrate-specific IgG (40, 41).
As the mean transfer rate of IgG2 in our study was close to
100%, limited transfer of IgG2 alone cannot explain the strong
differences in IgG response to carbohydrates in maternal and
cord blood. Additional factors, such as varying Fc region
glycosylation and consequent alteration of the binding strength
to different Fc receptors, may be responsible for limited transfer
of anti-carbohydrate antibodies (44). Of the Fc receptors
expressed in placental tissue only the role of FcRn is clear.
Other noncanonical Fc receptors, including FcγRI, FcγRII,
and FcγRIII, are widely unexplored and may contribute to
IgG transport (48). A recent study pointed to preferential
transplacental transfer of antibodies with digalactosylated
Fc glycans, binding selectively to FcRn and FcγRIIIa. These
antibodies activate NK cells, which in contrast to other immune
cells, are already fully competent in cord blood, leading to
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FIGURE 5 | IgG response to commensal intestinal bacteria is comparable in matched cord blood and maternal blood samples. (A) IgG reactivity to B. intestinalis for
cord blood (CB) and maternal blood (MB) samples (n = 26). (B) IgG reactivity to B. intestinalis for matched pairs of cord blood (red) and maternal blood (black).
(Continued)
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FIGURE 5 | Untreated bacteria are displayed in gray (dashed line). Histograms are related to data presented in (A). (C) IgG reactivity to B. thetaiotaomicron for cord
blood (CB) and maternal blood (MB) samples (n = 26). (D) IgG reactivity to B. thetaiotaomicron for matched pairs of cord blood (red) and maternal blood (black).
Untreated bacteria are displayed in gray (dashed line). Histograms are related to data presented in (C). (E) IgG reactivity to B. vulgatus for cord blood (CB) and
maternal blood (MB) samples (n = 26). (F) IgG reactivity to B. vulgatus for matched pairs of cord blood (red) and maternal blood (black). Untreated bacteria are
displayed in gray (dashed line). Histograms are related to data presented in (E).
the transfer of antibodies with the best functional potential
in the neonatal immune system (49). In addition, placental
transfer of IgG may not be the only mechanism of maternal IgG
transfer, as IgG from the amniotic fluid could be taken up by the
gastrointestinal route (50). Despite the occurrence of large pools
of diverse carbohydrate-specific antibodies in the blood serum of
adults and the immunogenicity of bacterial polysaccharides, the
general low IgG reactivity to glycans in cord blood indicates a
minor role of carbohydrate-specific antibodies in the protection
of neonates from pathogens.
To date, studies on the maternal transfer of anti-bacterial
antibodies to cord blood have focused on pathogenic bacteria
in the context of vaccination (15–18) and infections with
Neisseria gonorrhoeae, Salmonella typhosa and different strains of
Escherichia coli (21, 51). Our results demonstrate that antibodies
to commensal bacteria of the genus Bacteroides are also
transferred efficiently from the maternal to the fetal circulation.
We did not only detect broad IgG responses to different strains
of Bacteroides in cord blood, but also showed the consistent
overlap of bacterial antigens recognized by IgG of cord blood
and matched maternal blood. Besides a potential differential Fc
glycosylation of different antibodies, the difference in transport
efficiency compared with carbohydrate-specific IgGmay indicate
an involvement of different bacterial antigens (19), which include
proteins next to glycans. Slight differences in the IgG binding
of matched cord and maternal samples as well as differences
in the overall reactivity to the different Bacteroides species may
account for different bacterial antigens targeted. Accordingly,
Western blot data pointed to the presence of protein- and
lipopolysaccharide-specific IgG.
The transfer of antibodies recognizing pathogenic bacteria
significantly contributes to the protection of newborns from
infections. The rationale for the transfer of antibodies to
commensal bacteria is however less evident. A possible effect
is likely linked to the protection from translocated (52) or
potentially pathogenic bacteria (53, 54) from the intestinal
milieu to the blood circulation. Furthermore, antibodies
originally directed to commensal bacteria, can cross-react and
recognize additional bacterial species, including pathogenic
strains, through antigen mimicry that is widespread across
glycoconjugate antigens (55). Secretory IgA provided through
the breast milk also significantly contribute to shaping the gut
microbiota (56). Given that FcRn is expressed in human intestinal
epithelial cells and has been suggested to transport serum IgG to
the intestinal lumen (57–60), serum IgG of maternal origin are
also likely able to influence the expansion of the gut microbiota.
Prenatally transferred maternal IgG protects the newborn only
during the first months of life, as IgG levels start to decrease
usually between 2 and 6 months of age (61, 62). Accordingly, the
production of highly specific antibodies by the infant immune
system only starts postnatally (63). Despite the lack of significant
prenatal immunoglobulin production, probably due to a high
fetal immune tolerance (64), low and gestational age-dependent
IgM concentrations were detected in cord blood in our study
and in previous studies (23, 24). Analyzing IgM reactivity to
oligosaccharide antigens and commensal bacteria, however, we
did not observe any IgM reactivity in cord blood samples. The
lack of reactivity toward oligosaccharides support the notion that
the fetal immune system is not significantly exposed to microbes
prenatally, which could lead to the emergence of primary IgM
recognizing carbohydrate antigens. Our study confirms that
carbohydrate-specific and commensal-specific IgM only develop
postnatally. Analysis of blood and stool samples from infants
at different ages would allow to trace the postnatal emergence
of carbohydrate-specific IgM and to correlate the occurrence of
such antibodies with the process of gut microbial colonization.
The further study of the induction of carbohydrate-specific
antibodies and the time point of their occurrence in human
blood is important, as such antibodies play critical roles in the
protection against infections (6, 7) and in numerous diseases,




Goat anti-human IgG A488 and goat anti-human IgMA647 were
purchased from Jackson ImmunoResearch Laboratories (West
Grove, PA). Anti-human IgG DyLight488 and anti-human IgM
DyLight488 were obtained from Abcam (Cambridge, MA). Anti-
human IgGHRP was from Promega (Fitchburg, WI). Bacteroides
vulgatus (DSM 1447), Bacteroides intestinalis (DSM 17393), and
Bacteroides thetaiotaomicron (DSM 2079) were obtained from
the German Collection of Microorganisms and Cell Cultures
(DSMZ, Braunschweig, Germany).
Patients and Serum Samples
The study was approved by the cantonal Ethics Committee of
Zurich (KEK Nr. 2019-00150). All experiments were performed
in accordance with relevant guidelines and regulations. Informed
consent was obtained from all participants and/or their legal
guardians. Leftover maternal and cord blood samples were
obtained from the University hospital Zurich, Switzerland. The
study population comprised 30 full-term and 12 pre-term
neonates. Out of these 42 samples, matched maternal blood was
available for 26 full-term and 5 pre-term cord blood samples.
Blood was centrifuged at 3,000 x g for 15min at 4◦C and
sera were frozen at −20◦C. IgG and IgM concentrations were
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FIGURE 6 | IgM response to commensal intestinal bacteria is absent in cord blood. (A) IgM reactivity to B. intestinalis for cord blood (CB) and maternal blood (MB)
samples (n = 25). (B) IgM reactivity to B. intestinalis for matched pairs of cord blood (green) and maternal blood (black). Untreated bacteria are displayed in gray
(Continued)
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FIGURE 6 | (dashed line). Histograms are related to data presented in (A). (C) IgM reactivity to B. thetaiotaomicron for cord blood (CB) and maternal blood (MB)
samples (n = 23). (D) IgM reactivity to B. thetaiotaomicron for matched pairs of cord blood (green) and maternal blood (black). Untreated bacteria are displayed in
gray (dashed line). Histograms are related to data presented in (C). (E) IgM reactivity to B. vulgatus for cord blood (CB) and maternal blood (MB) samples (n = 26). (F)
IgM reactivity to B. vulgatus for matched pairs of cord blood (green) and maternal blood (black). Untreated bacteria are displayed in gray (dashed line). Histograms are
related to data presented in (E). Results with p-value < 0.05 are marked with asterisks.
FIGURE 7 | IgG of cord blood and matched maternal blood target identical antigens on commensal bacteria. IgG binding to components of bacterial cell lysates of
B. intestinalis (BIN), B. thetaiotaomicron (BTH), and B. vulgatus (BVU) for matched pairs of cord blood and maternal blood, using a serum dilution of 1:500.
determined by ELISA [IgG human ELISA Kit from Abnova
(KA3817), IgM human ELISA Kit from Abnova (KA1855),
Taipeh, China] according to the manufacturer’s protocols. IgG
transfer was calculated as proportion of the IgG concentration
in cord blood to the IgG concentration in maternal blood
([IgGcord/IgGmaternal]
∗100), according to (44).
Glycan Arrays
The human milk shotgun glycan microarray (version 223) has
been previously described (37) and was provided by the National
Center for Functional Glycomics (NCFG), BIDMC, Harvard
University. The shotgun glycan microarray slides were stored at
−20◦C, and before use, the arrays were allowed to come to room
temperature in a desiccator. Individual slides were loaded with
8-well format ProPlate Chambers (Grace Bio-Labs, OR, USA)
and hydrated with TSM-T [20mM Tris-HCl pH 7.4, 150mM
NaCl, 2mM CaCl2, 2mM MgCl2 (TSM) with 0.05% Tween].
To test antibody reactivity of individual serum samples, arrays
were incubated with serum diluted to 500µg/ml IgG in binding
buffer (TSM-T with 1% BSA) for 1 h at room temperature. After
incubation, slides were washed four times with TSM-T and for
times with TSM. For detection of IgG, slides were incubated
for 1 h at room temperature with 5µg/ml Alexa488-labeled goat
anti-human IgG in binding buffer. After washing as described
above, the slides were incubated for 1 h at room temperature
with 5µg/ml Alexa647 goat anti-human IgM and washed as
described with a final wash of four times with deionized water.
After spin-drying, arrays were scanned at 647 nm and 488 nm
using Innoscan 1100 AL (Innopsys, Carbonne, France). A mask
representing the layout of the array was fit to each image using
MAPIX analysis software version 8.5.0 (Innopsys, Carbonne,
France) and the mean fluorescence intensity of each spot was
calculated. The background signal was subtracted for each
spot, the mean of four replicates was calculated and negative
values were set to 1. For further analysis log (RFU) was used.
Microarray production and analyses were performed according
to the MIRAGE guidelines (68) (Supplementary Material).
Bacterial Cultures
Bacteroides species were cultivated anaerobically in rubber-sealed
hungate tubes at 37◦C in Peptone Yeast Glucosemedium (DSMZ,
medium no. 104 with 1.25 mg/ml glucose). At OD600 of 1.0 cells
were harvested in aliquots of 0.5ml. Cell pellets were received by
centrifugation at 13,000 x g for 1min, and phosphate-buffered
saline (PBS) washed pellets were either stored at −20◦C for cell
lysates or fixed with 2% paraformaldehyde in PBS for 15 min.
Flow Cytometry
Fixed bacteria were treated with diluted serum (1:100 for IgG,
1:10 for IgM) in PBS for 1 h at room temperature, washed
twice using PBS, stained with anti-human IgG DyLight488 or
anti-human IgM DyLight488 for 1 h at room temperature and
washed twice with PBS. The fluorescence signal was recorded
by a FACSCanto II Flow cytometer (BD Biosciences, Franklin
Lakes, NJ) and analysis was performed with the FlowJo software
(BD Bioscience).
Western Blots
Bacterial cell lysates were prepared from bacterial pellets,
resulting from 0.5ml culture at OD600 of 1.0, resuspended
in 200 µl SDS buffer (2% β-mercaptoethanol, 2% SDS, 10%
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glycerol in 50mM Tris-HCl, bromophenol blue, pH 6.8),
boiled at 99◦C for 15min. Fifteen microliter bacterial cell
lysates were run on 14% acrylamide gels at 80V for 2 h
and transferred onto PVDF at 250mA for 1 h. Membranes
were blocked overnight at 4◦C with 5% BSA in PBS-T (PBS
with 0.1% Tween20). Membranes were incubated with diluted
serum in PBS-T (1:500) for 2 h at room temperature, washed
four times for 5min using PBS-T, incubated with anti-human
IgG-HRP (1:5,000) in PBS-T for 1 h at room temperature,
washed four times for 5min with PBS-T and detected using
SuperSignal R© West Pico chemiluminescence substrate (Thermo
Fisher Scientific, Waltham, MA) and a Fujifilm LAS-4000
luminescence image analyzer (GE Healthcare, Chicago, IL).
Matched cord and maternal blood samples were used on the
same membrane, which was cut after transfer, and detection
of membrane pieces incubated with matched samples was
performed simultaneously.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
(GraphPad software, San Diego, CA). For the comparison of
two groups of paired samples (cord blood vs. maternal blood,
IgG total vs. IgG2), either a paired student’s t-test for Gauss-
distributed or aWilcoxonmatched pairs signed rank test for non-
Gauss distributed samples was used. For unpaired groups (pre-
term vs. full-term), an unpaired t-test withWelch’s correction was
used. Results with p-value ≤ 0.05 were considered significantly
different and marked with asterisks. For quantile normalization
and correlation analysis a software tool run on R (version V3.6.1)
using the “limma” package (69) with the functions cor.test() and
normalizeQuantiles() was used.
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